Back to search

Article

Trends and variation in andexanet alfa for the reversal of direct oral anticoagulants in NHS Trusts in England

2025-01-22

Abstract excerpt

Andexanet alfa was recommended by the National Institute for Health and Clinical Excellence (NICE) as an option in the management of major gastrointestinal bleeding in patients taking apixaban or rivaroxaban in May 2021. To assess the uptake of andexanet alfa, we analysed pharmacy stock control data from NHS Trusts in England using the openly available Secondary Care Medicines Dataset. Between May 2021 and July 20...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3e0acaa-ab4d-53ca-afa2-8c63df4dc942
DOI
10.1101/2025.01.21.25320733
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Trends and variation in andexanet alfa for the reversal of direct oral anticoagulants in NHS Trusts in EnglandDOI 10.1101/2025.01.21.25320733
Select a neighboring publication to make it the new centre.